Back

GLP-1R expression protects against 58 diseases but raises risk for 34 diseases and neonatal health

2026-01-26 public and global health Title + abstract only
View on medRxiv
Show abstract

Cardiometabolic gene-target drugs such as Glucagon-Like Peptide 1 Receptor agonists are used extensively, yet risks and repurposing have not been systematically evaluated across a comprehensive set of diseases. We use Phenome-wide Mendelian Randomization to test GLP1R gene expression and Cholesteryl Ester Transfer Protein (CETP) concentration, two promising cardiometabolic drug targets, on risk of 396 diseases based on sex-specific, ancestry-specific, genome-wide association studies in UK Bioban...

Predicted journal destinations